SWI/SNF nucleosome remodellers and cancer
BG Wilson, CWM Roberts - Nature Reviews Cancer, 2011 - nature.com
SWI/SNF chromatin remodelling complexes use the energy of ATP hydrolysis to remodel
nucleosomes and to modulate transcription. Growing evidence indicates that these …
nucleosomes and to modulate transcription. Growing evidence indicates that these …
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms
DC Hargreaves, GR Crabtree - Cell research, 2011 - nature.com
Macromolecular assemblies that regulate chromatin structure using the energy of ATP
hydrolysis have critical roles in development, cancer, and stem cell biology. The ATPases of …
hydrolysis have critical roles in development, cancer, and stem cell biology. The ATPases of …
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor
gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large …
gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large …
The spectrum of SWI/SNF mutations, ubiquitous in human cancers
AH Shain, JR Pollack - PloS one, 2013 - journals.plos.org
SWI/SNF is a multi-subunit chromatin remodeling complex that uses the energy of ATP
hydrolysis to reposition nucleosomes, thereby modulating gene expression. Accumulating …
hydrolysis to reposition nucleosomes, thereby modulating gene expression. Accumulating …
The VHL/HIF axis in clear cell renal carcinoma
C Shen, WG Kaelin Jr - Seminars in cancer biology, 2013 - Elsevier
Inactivation of the VHL tumor suppressor protein (pVHL) is a common event in clear cell
renal carcinoma, which is the most common form of kidney cancer. pVHL performs many …
renal carcinoma, which is the most common form of kidney cancer. pVHL performs many …
Molecular genetics of clear-cell renal cell carcinoma
J Brugarolas - Journal of clinical oncology, 2014 - ascopubs.org
Renal cell carcinoma of clear-cell type (ccRCC) is an enigmatic tumor type, characterized by
frequent inactivation of the VHL gene (infrequently mutated in other tumor types) …
frequent inactivation of the VHL gene (infrequently mutated in other tumor types) …
A secreted PTEN phosphatase that enters cells to alter signaling and survival
BD Hopkins, B Fine, N Steinbach, M Dendy, Z Rapp… - Science, 2013 - science.org
Phosphatase and tensin homolog on chromosome ten (PTEN) is a tumor suppressor and an
antagonist of the phosphoinositide-3 kinase (PI3K) pathway. We identified a 576–amino …
antagonist of the phosphoinositide-3 kinase (PI3K) pathway. We identified a 576–amino …
The SWI/SNF protein PBRM1 restrains VHL-loss-driven clear cell renal cell carcinoma
AM Nargund, CG Pham, Y Dong, PI Wang… - Cell reports, 2017 - cell.com
PBRM1 is the second most commonly mutated gene after VHL in clear cell renal cell
carcinoma (ccRCC). However, the biological consequences of PBRM1 mutations for kidney …
carcinoma (ccRCC). However, the biological consequences of PBRM1 mutations for kidney …
SWI/SNF chromatin remodeling complexes and cancer
JA Biegel, TM Busse… - American Journal of …, 2014 - Wiley Online Library
The identification of mutations and deletions in the SMARCB1 locus in chromosome band
22q11. 2 in pediatric rhabdoid tumors provided the first evidence for the involvement of the …
22q11. 2 in pediatric rhabdoid tumors provided the first evidence for the involvement of the …
Driver mutations of cancer epigenomes
Epigenetic alterations are associated with all aspects of cancer, from tumor initiation to
cancer progression and metastasis. It is now well understood that both losses and gains of …
cancer progression and metastasis. It is now well understood that both losses and gains of …